Sanofi

News

Sanofi's Paris HQ raided in tax fraud probe

Sanofi's headquarters in Paris has been raided as part of an investigation into a financing deal, said to be related to a historical acquisition.

R&D

Knowledge Quarter, King's Cross, London, UK

From physics to pharma: How Aqemia is reinventing the future...

The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.

News

Sanofi's type 1 diabetes drug poised for EU rollout

Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug designed to delay the progression of type 1 diabetes.

Patients

teenager with insulin injector on her bed with teddy bears

World Diabetes Day: Type 1 diabetes in the spotlight and und...

This World Diabetes Day, Sanofi UK and DigiBete are hosting a pop-up event in Leeds to spotlight type 1 diabetes and the need for early detection.

News

CHMP backs first drug for lung disease bronchiectasis

Insmed gets EU recommendation for first non-cystic fibrosis bronchiectasis therapy Brinsupri, plus other CHMP decisions.

News

Amgen, AZ's Tezspire challenges Dupixent in nasal polyps

Amgen and AstraZeneca's fast-growing asthma drug Tezspire is now poised to take on rival Dupixent in chronic rhinosinusitis with nasal polyps.

Sanofi's Paris HQ raided in tax fraud probe

From physics to pharma: How Aqemia is reinventing the future...

Sanofi's type 1 diabetes drug poised for EU rollout

World Diabetes Day: Type 1 diabetes in the spotlight and und...

CHMP backs first drug for lung disease bronchiectasis

Amgen, AZ's Tezspire challenges Dupixent in nasal polyps

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks